A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer

This study has been terminated.
(The study was stopped due to unbalanced side effects)
Sponsor:
Information provided by (Responsible Party):
Dr Merav Ben-David, Water-Jel
ClinicalTrials.gov Identifier:
NCT01597921
First received: May 10, 2012
Last updated: August 8, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)